Alkem Of India Recalls Batches Of Ampicillin Injectables
This article was originally published in PharmAsia News
Executive Summary
India's Alkem announced it was recalling six batches of ampicillin injections from foreign markets, particularly in France and Africa. The recall followed a retesting of the drug ordered after reports last October that the drug as delivered did not contain the specified dosage. France's AFFSAPS tested the drugs and, along with other European laboratories, reported the failures. Alkem said the drug continues to pass U.S. standards, but decided to recall the drug. (Click here for more